Tessa Crume
Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 10 | 2026 | 914 | 3.040 |
Why?
| | Prenatal Exposure Delayed Effects | 13 | 2025 | 675 | 1.990 |
Why?
| | Medical Record Linkage | 3 | 2021 | 68 | 1.840 |
Why?
| | Population Surveillance | 5 | 2022 | 485 | 1.590 |
Why?
| | Diabetes, Gestational | 8 | 2018 | 321 | 1.500 |
Why?
| | Diabetes Mellitus, Type 1 | 24 | 2026 | 3890 | 1.490 |
Why?
| | Diabetes Mellitus, Type 2 | 16 | 2026 | 2583 | 1.320 |
Why?
| | Adiposity | 10 | 2022 | 543 | 1.130 |
Why?
| | Cannabis | 5 | 2025 | 509 | 1.120 |
Why?
| | Breast Feeding | 6 | 2018 | 448 | 1.060 |
Why?
| | Pregnancy Outcome | 4 | 2019 | 476 | 1.050 |
Why?
| | Electronic Health Records | 7 | 2026 | 1173 | 0.980 |
Why?
| | Smoking Cessation | 2 | 2019 | 439 | 0.900 |
Why?
| | Pregnancy | 22 | 2025 | 7190 | 0.840 |
Why?
| | Autism Spectrum Disorder | 6 | 2025 | 412 | 0.840 |
Why?
| | Obesity | 9 | 2022 | 3077 | 0.810 |
Why?
| | Adolescent | 44 | 2026 | 22428 | 0.790 |
Why?
| | Body Mass Index | 13 | 2022 | 2438 | 0.750 |
Why?
| | Young Adult | 26 | 2026 | 14105 | 0.720 |
Why?
| | Child | 46 | 2026 | 22633 | 0.720 |
Why?
| | Colorado | 14 | 2021 | 4564 | 0.700 |
Why?
| | Body Composition | 2 | 2016 | 706 | 0.690 |
Why?
| | Child Development | 6 | 2024 | 484 | 0.670 |
Why?
| | Infant, Newborn | 14 | 2025 | 6429 | 0.660 |
Why?
| | Patient Acceptance of Health Care | 2 | 2026 | 885 | 0.660 |
Why?
| | Prevalence | 13 | 2026 | 2834 | 0.630 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 3 | 2016 | 59 | 0.600 |
Why?
| | Female | 60 | 2026 | 78271 | 0.600 |
Why?
| | Cost Savings | 1 | 2019 | 86 | 0.590 |
Why?
| | Information Storage and Retrieval | 1 | 2020 | 121 | 0.590 |
Why?
| | Marijuana Use | 2 | 2024 | 213 | 0.580 |
Why?
| | Dietary Carbohydrates | 2 | 2016 | 151 | 0.560 |
Why?
| | Adult | 32 | 2026 | 40449 | 0.540 |
Why?
| | Child, Preschool | 24 | 2025 | 11787 | 0.530 |
Why?
| | Humans | 77 | 2026 | 144759 | 0.530 |
Why?
| | Cigarette Smoking | 1 | 2019 | 99 | 0.520 |
Why?
| | Beverages | 2 | 2015 | 69 | 0.520 |
Why?
| | Pregnancy in Diabetics | 3 | 2018 | 121 | 0.510 |
Why?
| | Male | 50 | 2026 | 72315 | 0.510 |
Why?
| | Cardiovascular Diseases | 10 | 2024 | 2168 | 0.500 |
Why?
| | Infant | 16 | 2025 | 10034 | 0.490 |
Why?
| | Mothers | 4 | 2025 | 775 | 0.480 |
Why?
| | Medical Marijuana | 1 | 2018 | 123 | 0.470 |
Why?
| | Child of Impaired Parents | 2 | 2015 | 38 | 0.460 |
Why?
| | Poverty | 1 | 2019 | 529 | 0.460 |
Why?
| | Pregnancy Complications | 2 | 2019 | 592 | 0.460 |
Why?
| | Abdominal Fat | 2 | 2013 | 50 | 0.450 |
Why?
| | Dietary Proteins | 1 | 2016 | 136 | 0.440 |
Why?
| | Motivation | 1 | 2019 | 610 | 0.430 |
Why?
| | Hospitalization | 2 | 2026 | 2433 | 0.430 |
Why?
| | United States | 21 | 2026 | 15966 | 0.430 |
Why?
| | Dietary Fats | 1 | 2016 | 314 | 0.420 |
Why?
| | Maternal-Fetal Exchange | 1 | 2015 | 169 | 0.400 |
Why?
| | Emergency Service, Hospital | 3 | 2026 | 2310 | 0.400 |
Why?
| | Insulin Resistance | 4 | 2016 | 1241 | 0.400 |
Why?
| | Diet | 3 | 2020 | 1273 | 0.390 |
Why?
| | Diet, Reducing | 1 | 2013 | 91 | 0.380 |
Why?
| | Adolescent Development | 1 | 2013 | 72 | 0.380 |
Why?
| | Brain | 1 | 2025 | 2933 | 0.380 |
Why?
| | Retrospective Studies | 16 | 2026 | 17066 | 0.370 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2014 | 149 | 0.370 |
Why?
| | Hyperinsulinism | 1 | 2013 | 113 | 0.370 |
Why?
| | Linear Models | 5 | 2024 | 854 | 0.370 |
Why?
| | Adiponectin | 2 | 2013 | 244 | 0.370 |
Why?
| | Cohort Studies | 12 | 2021 | 5960 | 0.350 |
Why?
| | Down-Regulation | 1 | 2013 | 627 | 0.340 |
Why?
| | Diabetic Angiopathies | 3 | 2019 | 263 | 0.330 |
Why?
| | Mental Disorders | 1 | 2019 | 1168 | 0.310 |
Why?
| | Diabetes Mellitus | 3 | 2026 | 1098 | 0.310 |
Why?
| | Skiing | 2 | 2020 | 49 | 0.290 |
Why?
| | Registries | 2 | 2023 | 2385 | 0.280 |
Why?
| | Energy Metabolism | 1 | 2015 | 935 | 0.280 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2021 | 98 | 0.280 |
Why?
| | Risk Factors | 17 | 2024 | 10779 | 0.280 |
Why?
| | Insulin-Secreting Cells | 1 | 2013 | 388 | 0.270 |
Why?
| | Middle Aged | 12 | 2026 | 35875 | 0.270 |
Why?
| | Air Pollution | 3 | 2021 | 327 | 0.270 |
Why?
| | Birth Weight | 5 | 2022 | 522 | 0.260 |
Why?
| | Multimorbidity | 2 | 2025 | 63 | 0.260 |
Why?
| | Fetal Growth Retardation | 1 | 2013 | 587 | 0.260 |
Why?
| | Weight Loss | 1 | 2013 | 836 | 0.260 |
Why?
| | Diet Surveys | 3 | 2016 | 91 | 0.260 |
Why?
| | Prospective Studies | 7 | 2025 | 7990 | 0.260 |
Why?
| | Islets of Langerhans | 3 | 2023 | 833 | 0.240 |
Why?
| | Algorithms | 3 | 2024 | 1837 | 0.240 |
Why?
| | Child Nutritional Physiological Phenomena | 2 | 2019 | 106 | 0.230 |
Why?
| | Case-Control Studies | 10 | 2025 | 3604 | 0.230 |
Why?
| | Air Pollutants | 2 | 2021 | 438 | 0.230 |
Why?
| | Emigration and Immigration | 1 | 2025 | 66 | 0.220 |
Why?
| | Longitudinal Studies | 7 | 2020 | 2947 | 0.220 |
Why?
| | Organ Size | 1 | 2025 | 463 | 0.210 |
Why?
| | Amygdala | 1 | 2025 | 198 | 0.200 |
Why?
| | Problem Behavior | 1 | 2025 | 102 | 0.200 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2016 | 181 | 0.200 |
Why?
| | Autoimmunity | 4 | 2023 | 926 | 0.190 |
Why?
| | Subcutaneous Fat | 2 | 2014 | 78 | 0.190 |
Why?
| | Blood Glucose | 6 | 2024 | 2327 | 0.190 |
Why?
| | Emigrants and Immigrants | 1 | 2025 | 157 | 0.190 |
Why?
| | Athletic Injuries | 2 | 2020 | 569 | 0.190 |
Why?
| | Vehicle Emissions | 2 | 2021 | 62 | 0.190 |
Why?
| | Lipid Metabolism | 2 | 2019 | 527 | 0.190 |
Why?
| | Cannabinoids | 2 | 2022 | 182 | 0.190 |
Why?
| | Child Behavior | 1 | 2024 | 236 | 0.180 |
Why?
| | Exercise | 2 | 2018 | 2201 | 0.180 |
Why?
| | Hyperlipidemias | 1 | 2023 | 122 | 0.180 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2925 | 0.180 |
Why?
| | Time-to-Treatment | 1 | 2024 | 243 | 0.180 |
Why?
| | C-Peptide | 2 | 2013 | 189 | 0.180 |
Why?
| | Survivors | 2 | 2024 | 520 | 0.170 |
Why?
| | Georgia | 1 | 2021 | 83 | 0.170 |
Why?
| | Allostasis | 1 | 2021 | 17 | 0.170 |
Why?
| | Utah | 1 | 2021 | 81 | 0.170 |
Why?
| | North Carolina | 1 | 2021 | 128 | 0.170 |
Why?
| | New York | 1 | 2021 | 125 | 0.170 |
Why?
| | Public Health | 1 | 2026 | 566 | 0.160 |
Why?
| | Insurance Claim Reporting | 1 | 2020 | 25 | 0.160 |
Why?
| | Diet, Mediterranean | 1 | 2020 | 28 | 0.160 |
Why?
| | Age Distribution | 1 | 2021 | 403 | 0.160 |
Why?
| | Sex Distribution | 1 | 2021 | 386 | 0.160 |
Why?
| | International Classification of Diseases | 1 | 2021 | 147 | 0.160 |
Why?
| | Cause of Death | 1 | 2002 | 471 | 0.160 |
Why?
| | Volatilization | 1 | 2019 | 52 | 0.150 |
Why?
| | Age Factors | 5 | 2024 | 3333 | 0.150 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 126 | 0.150 |
Why?
| | Nebulizers and Vaporizers | 1 | 2019 | 62 | 0.150 |
Why?
| | Morbidity | 1 | 2020 | 323 | 0.150 |
Why?
| | Gonadal Dysgenesis | 1 | 2019 | 7 | 0.150 |
Why?
| | Socioeconomic Factors | 2 | 2020 | 1326 | 0.150 |
Why?
| | Proportional Hazards Models | 4 | 2026 | 1325 | 0.150 |
Why?
| | Hippocampus | 1 | 2025 | 965 | 0.150 |
Why?
| | Prader-Willi Syndrome | 1 | 2019 | 31 | 0.150 |
Why?
| | Probability | 1 | 2020 | 310 | 0.150 |
Why?
| | Marfan Syndrome | 1 | 2019 | 46 | 0.150 |
Why?
| | DiGeorge Syndrome | 1 | 2019 | 34 | 0.150 |
Why?
| | Bias | 1 | 2020 | 202 | 0.150 |
Why?
| | Puberty, Precocious | 1 | 2018 | 12 | 0.150 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 312 | 0.150 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2019 | 56 | 0.150 |
Why?
| | Autistic Disorder | 1 | 2021 | 211 | 0.150 |
Why?
| | Waist Circumference | 3 | 2014 | 139 | 0.140 |
Why?
| | Incidence | 5 | 2026 | 2879 | 0.140 |
Why?
| | Environmental Exposure | 2 | 2021 | 588 | 0.140 |
Why?
| | Fragile X Syndrome | 1 | 2019 | 118 | 0.140 |
Why?
| | Gardening | 1 | 2018 | 13 | 0.140 |
Why?
| | Mood Disorders | 1 | 2019 | 140 | 0.140 |
Why?
| | Diet Therapy | 1 | 2018 | 37 | 0.140 |
Why?
| | Alcohol Drinking | 1 | 2025 | 826 | 0.130 |
Why?
| | Metabolomics | 2 | 2020 | 727 | 0.130 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2019 | 108 | 0.130 |
Why?
| | Dronabinol | 1 | 2019 | 247 | 0.120 |
Why?
| | Community Participation | 1 | 2018 | 132 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2015 | 142 | 0.120 |
Why?
| | Child Abuse | 1 | 2002 | 551 | 0.120 |
Why?
| | Nicotine | 1 | 2019 | 331 | 0.120 |
Why?
| | Preventive Health Services | 1 | 2018 | 152 | 0.120 |
Why?
| | Anxiety Disorders | 1 | 2019 | 373 | 0.120 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5408 | 0.120 |
Why?
| | Global Health | 1 | 2019 | 401 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 920 | 0.110 |
Why?
| | Statistics, Nonparametric | 1 | 2016 | 427 | 0.110 |
Why?
| | Models, Statistical | 1 | 2019 | 681 | 0.110 |
Why?
| | Vascular Stiffness | 1 | 2020 | 486 | 0.110 |
Why?
| | Leptin | 2 | 2014 | 245 | 0.110 |
Why?
| | Program Evaluation | 1 | 2019 | 948 | 0.110 |
Why?
| | Erythrocyte Membrane | 1 | 2015 | 54 | 0.110 |
Why?
| | Drug Users | 1 | 2015 | 42 | 0.110 |
Why?
| | Stress, Psychological | 1 | 2023 | 1152 | 0.110 |
Why?
| | Health | 1 | 2015 | 81 | 0.110 |
Why?
| | Time Factors | 3 | 2025 | 7173 | 0.110 |
Why?
| | Computers | 1 | 2014 | 67 | 0.110 |
Why?
| | Gestational Age | 2 | 2024 | 975 | 0.100 |
Why?
| | Carbohydrates | 1 | 2014 | 66 | 0.100 |
Why?
| | Family Health | 1 | 2015 | 191 | 0.100 |
Why?
| | Cross-Sectional Studies | 3 | 2025 | 5868 | 0.100 |
Why?
| | Multivariate Analysis | 2 | 2021 | 1539 | 0.100 |
Why?
| | Television | 1 | 2014 | 72 | 0.100 |
Why?
| | Risk | 2 | 2013 | 911 | 0.100 |
Why?
| | Databases, Factual | 1 | 2019 | 1486 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 404 | 0.100 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 6048 | 0.100 |
Why?
| | HLA Antigens | 1 | 2014 | 225 | 0.100 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 185 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 1 | 2025 | 3863 | 0.090 |
Why?
| | Phenotype | 3 | 2026 | 3162 | 0.090 |
Why?
| | Fetal Development | 2 | 2016 | 299 | 0.090 |
Why?
| | Skinfold Thickness | 1 | 2012 | 43 | 0.090 |
Why?
| | Health Behavior | 1 | 2018 | 785 | 0.090 |
Why?
| | Down Syndrome | 1 | 2019 | 534 | 0.090 |
Why?
| | Muscle Cells | 1 | 2012 | 42 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1169 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 67 | 0.090 |
Why?
| | Autoantibodies | 1 | 2019 | 1501 | 0.090 |
Why?
| | Fetal Blood | 1 | 2014 | 342 | 0.090 |
Why?
| | Prognosis | 1 | 2020 | 4282 | 0.090 |
Why?
| | Thinness | 1 | 2012 | 99 | 0.090 |
Why?
| | Health Promotion | 1 | 2018 | 774 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 173 | 0.090 |
Why?
| | Intra-Abdominal Fat | 1 | 2012 | 100 | 0.080 |
Why?
| | Lactation | 1 | 2012 | 192 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1560 | 0.080 |
Why?
| | Parents | 2 | 2021 | 1403 | 0.080 |
Why?
| | Heart Failure | 1 | 2024 | 2323 | 0.080 |
Why?
| | Weight Gain | 1 | 2014 | 556 | 0.080 |
Why?
| | Milk, Human | 1 | 2012 | 172 | 0.080 |
Why?
| | Sex Factors | 1 | 2016 | 2112 | 0.080 |
Why?
| | Overweight | 1 | 2015 | 609 | 0.080 |
Why?
| | Comorbidity | 2 | 2025 | 1658 | 0.080 |
Why?
| | Substance-Related Disorders | 1 | 2019 | 1094 | 0.080 |
Why?
| | Mental Health Services | 1 | 2015 | 473 | 0.070 |
Why?
| | Genotype | 1 | 2014 | 1833 | 0.070 |
Why?
| | Food Microbiology | 2 | 2006 | 73 | 0.070 |
Why?
| | Insulin | 2 | 2022 | 2507 | 0.070 |
Why?
| | Maternal Exposure | 1 | 2011 | 213 | 0.070 |
Why?
| | Disease Progression | 3 | 2021 | 2847 | 0.070 |
Why?
| | Inflammation | 1 | 2019 | 2878 | 0.070 |
Why?
| | Self Report | 1 | 2012 | 872 | 0.070 |
Why?
| | Aged | 4 | 2021 | 25913 | 0.060 |
Why?
| | Docosahexaenoic Acids | 2 | 2021 | 83 | 0.060 |
Why?
| | Particulate Matter | 2 | 2021 | 347 | 0.060 |
Why?
| | Risk Assessment | 1 | 2016 | 3671 | 0.060 |
Why?
| | Salmonella enteritidis | 1 | 2006 | 17 | 0.060 |
Why?
| | Salmonella Food Poisoning | 1 | 2006 | 12 | 0.060 |
Why?
| | Epigenesis, Genetic | 1 | 2011 | 684 | 0.060 |
Why?
| | Analgesics, Opioid | 1 | 2015 | 1143 | 0.060 |
Why?
| | beta-Lactamases | 1 | 2006 | 51 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2021 | 780 | 0.060 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2006 | 81 | 0.060 |
Why?
| | Salmonella | 1 | 2006 | 61 | 0.060 |
Why?
| | Salmonella Infections | 1 | 2006 | 60 | 0.060 |
Why?
| | Age of Onset | 2 | 2019 | 551 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3409 | 0.060 |
Why?
| | Anthropometry | 2 | 2018 | 200 | 0.060 |
Why?
| | Nutrition Surveys | 2 | 2016 | 282 | 0.050 |
Why?
| | Cholesterol, HDL | 2 | 2016 | 200 | 0.050 |
Why?
| | Puberty | 2 | 2018 | 140 | 0.050 |
Why?
| | Pregnancy Trimester, First | 1 | 2025 | 136 | 0.050 |
Why?
| | Parity | 1 | 2024 | 109 | 0.050 |
Why?
| | Triglycerides | 2 | 2016 | 520 | 0.050 |
Why?
| | Alabama | 1 | 2023 | 33 | 0.050 |
Why?
| | Medical Records | 1 | 2023 | 187 | 0.050 |
Why?
| | Oxylipins | 1 | 2023 | 47 | 0.050 |
Why?
| | Death Certificates | 1 | 2002 | 32 | 0.050 |
Why?
| | Smokers | 1 | 2023 | 137 | 0.050 |
Why?
| | Nutritional Status | 2 | 2016 | 354 | 0.050 |
Why?
| | Minority Groups | 1 | 2024 | 282 | 0.040 |
Why?
| | Disease Susceptibility | 2 | 2015 | 348 | 0.040 |
Why?
| | Hydroxyeicosatetraenoic Acids | 1 | 2021 | 35 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2023 | 541 | 0.040 |
Why?
| | Indians, North American | 2 | 2019 | 647 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2026 | 1985 | 0.040 |
Why?
| | Parenting | 1 | 2024 | 318 | 0.040 |
Why?
| | Seroconversion | 1 | 2020 | 49 | 0.040 |
Why?
| | Regression Analysis | 2 | 2013 | 1003 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2021 | 271 | 0.040 |
Why?
| | 2-Propanol | 1 | 2019 | 20 | 0.040 |
Why?
| | Biomarkers | 3 | 2019 | 4271 | 0.040 |
Why?
| | Limit of Detection | 1 | 2019 | 97 | 0.040 |
Why?
| | Bacterial Proteins | 1 | 2006 | 955 | 0.040 |
Why?
| | Pulse Wave Analysis | 1 | 2020 | 266 | 0.040 |
Why?
| | Calibration | 1 | 2019 | 151 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 179 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 395 | 0.040 |
Why?
| | Sexual Maturation | 1 | 2018 | 51 | 0.040 |
Why?
| | Menarche | 1 | 2018 | 52 | 0.040 |
Why?
| | Surface Properties | 1 | 2019 | 410 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2019 | 249 | 0.030 |
Why?
| | Fibrinogen | 1 | 2019 | 177 | 0.030 |
Why?
| | Carbon | 1 | 2019 | 203 | 0.030 |
Why?
| | Healthy Lifestyle | 1 | 2018 | 37 | 0.030 |
Why?
| | Body Height | 1 | 2018 | 202 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2024 | 727 | 0.030 |
Why?
| | Fruit | 1 | 2018 | 152 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2019 | 416 | 0.030 |
Why?
| | Logistic Models | 1 | 2002 | 2117 | 0.030 |
Why?
| | Chronic Disease | 1 | 2023 | 1813 | 0.030 |
Why?
| | Vegetables | 1 | 2018 | 170 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2019 | 377 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1047 | 0.030 |
Why?
| | Social Class | 1 | 2018 | 268 | 0.030 |
Why?
| | Seasons | 1 | 2019 | 556 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2019 | 576 | 0.030 |
Why?
| | Family | 1 | 2021 | 679 | 0.030 |
Why?
| | Eggs | 2 | 2006 | 25 | 0.030 |
Why?
| | Marijuana Smoking | 1 | 2019 | 250 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1217 | 0.030 |
Why?
| | Lipoproteins, LDL | 1 | 2016 | 119 | 0.030 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2022 | 699 | 0.030 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2015 | 52 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 947 | 0.030 |
Why?
| | Diet Records | 1 | 2015 | 85 | 0.030 |
Why?
| | Community Health Planning | 1 | 2015 | 41 | 0.030 |
Why?
| | Overnutrition | 1 | 2014 | 30 | 0.030 |
Why?
| | Social Support | 1 | 2018 | 652 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2015 | 358 | 0.020 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2013 | 39 | 0.020 |
Why?
| | Eicosapentaenoic Acid | 1 | 2013 | 36 | 0.020 |
Why?
| | Energy Intake | 1 | 2016 | 499 | 0.020 |
Why?
| | Body Constitution | 1 | 2012 | 51 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2020 | 8265 | 0.020 |
Why?
| | Intracellular Space | 1 | 2012 | 66 | 0.020 |
Why?
| | Body Size | 1 | 2012 | 95 | 0.020 |
Why?
| | Milk | 1 | 2012 | 119 | 0.020 |
Why?
| | Fasting | 1 | 2013 | 277 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 128 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1720 | 0.020 |
Why?
| | Mental Health | 1 | 2018 | 790 | 0.020 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2010 | 5 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 114 | 0.020 |
Why?
| | E-Selectin | 1 | 2010 | 61 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2016 | 684 | 0.020 |
Why?
| | Lipids | 1 | 2015 | 710 | 0.020 |
Why?
| | Health Status | 1 | 2015 | 836 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 2010 | 178 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 902 | 0.020 |
Why?
| | Intestines | 1 | 2012 | 358 | 0.020 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 354 | 0.020 |
Why?
| | Blood Pressure | 1 | 2015 | 1769 | 0.020 |
Why?
| | Chickens | 1 | 2006 | 191 | 0.010 |
Why?
| | Biomedical Research | 1 | 2012 | 710 | 0.010 |
Why?
| | Meat | 1 | 2006 | 93 | 0.010 |
Why?
| | Travel | 1 | 2006 | 136 | 0.010 |
Why?
| | Cattle | 1 | 2006 | 1000 | 0.010 |
Why?
| | Odds Ratio | 1 | 2006 | 1075 | 0.010 |
Why?
| | Animals | 3 | 2012 | 38058 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2006 | 1907 | 0.010 |
Why?
|
|
Crume's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|